Zobrazeno 1 - 10
of 311
pro vyhledávání: '"M Kohlhäufl"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2014 (2014)
Ductal adenocarcinoma of the pancreas is a lethal disease. Surgical extirpation only offers the slim chance for long-term survival in localized disease. We report on a 73 year old female patient who initially underwent successful resection of pancrea
Externí odkaz:
https://doaj.org/article/36c63ca0186f43fd97f508598d514093
Autor:
R. F. Falkenstern-Ge, M. Kimmich, M. Wohlleber, A. Grabner, G. Friedel, G. Ott, I. Leuschner, M. Kohlhäufl
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
A 30-year old woman was referred to our center because of suspicion of a primary lung tumor of the right upper lobe. Histological examination of the lung lesion revealed lung metastasis of a previously treated alveolar soft part sarcoma of the muscul
Externí odkaz:
https://doaj.org/article/9349bee2be4a4142950292287bf1d24c
Publikováno v:
Case Reports in Pulmonology, Vol 2013 (2013)
Endoscopic lung volume reduction using lung sealant is a very new and innovative treatment option for patients with severe progressive and irreversible lung emphysema. A 55-year-old ex-smoker (60 pack years) referred to our center because of severe l
Externí odkaz:
https://doaj.org/article/44c93767e74b472597aa30767daf5264
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Introduction. Pleural mesothelioma with metastasis to the subcutaneous tissue of the abdominal wall at first diagnosis and without penetration into the peritoneum is an extremely rare clinical presentation. Methods. Patients with pleural mesothelioma
Externí odkaz:
https://doaj.org/article/d87c705a22f446958c2db40a5b49508e
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Background. Sweat gland carcinoma is a rare malignancy with a high metastatic potential seen more commonly in elderly patients. The scalp is the most common site of occurrence and it usually spreads to regional lymph nodes. Liver, lungs, and bones ar
Externí odkaz:
https://doaj.org/article/eae1ec012f7e4ff1b88cfc0222230430
Publikováno v:
Pneumologie. 71:S1-S125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243070a2affd7b3343a5fbd3d329cc3e
https://doi.org/10.1055/s-0037-1598464
https://doi.org/10.1055/s-0037-1598464
Autor:
M. Kohlhäufl, K. Husemann
Publikováno v:
Atemwegs- und Lungenkrankheiten. 41:522-532
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c9fc2f369e5be395c8f62e5c9743f89
https://doi.org/10.5414/atx01063
https://doi.org/10.5414/atx01063
Autor:
M. Kohlhäufl, K. Husemann
Publikováno v:
Der Pneumologe. 12:490-499
Hintergrund Der „Lung clearance index“ (LCI) ist die am haufigsten berichtete Messgrose des Mehratemzug-Gasauswaschtests („multiple breath washout“, MBW) und erfasst als globaler Marker Verteilungsstorungen der Ventilation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::787aa16bf042fbb0cc92ec1dc9e7b681
https://doi.org/10.1007/s10405-015-0004-3
https://doi.org/10.1007/s10405-015-0004-3
Autor:
Ingo Baumann, F.-M. Müller, J. Bend, A. Möller, Doris Staab, Carsten Schwarz, W. Bremer, Ernst Rietschel, R.-P. Vonberg, Burkhard Tümmler, R. Mahlberg, R. Bruns, Christina Smaczny, J. Riedler, B. Schulte-Hubbert, M. Abele-Horn, H. Hebestreit, R. Fischer, M. Kohlhäufl, F. Brunsmann, L. Sedlacek, S. Illing, J. Zerlik, Helmut Sitter, M. Puderbach, J. Bargon, Jochen G. Mainz, T. O. Hirche, Assen Koitschev, Michael Hogardt, Isidor Huttegger, Manfred Ballmann, S. Pfeiffer-Auler, C. Geidel, Tof Wagner
Publikováno v:
Monatsschrift Kinderheilkunde. 163:590-599
Mukoviszidose (zystische Fibrose, CF) ist eine der haufigsten autosomal-rezessiv vererbten Erkrankungen der kaukasischen Bevolkerung. Der genetische Defekt im CFTR-Gen fuhrt zu einer Verringerung des Chloridionentransports an der Zellmembran. Die res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cea5caf19930e1be2c21b34ebd157c6
https://doi.org/10.1007/s00112-015-3354-3
https://doi.org/10.1007/s00112-015-3354-3
Autor:
German Ott, Kimmich M, M Wohlleber, Bode-Erdmann S, M Kohlhäufl, R. F. Falkenstern-Ge, Godehard Friedel
Publikováno v:
Oncology & Cancer Case Reports.
We The immune checkpoint modulator, nivolumab (BMS-936558/ONO-4538), is the first PD-1 inhibitor to gain regulatory approval, for the treatment of patients with unresectable melanoma. Nivolumab received FDA approval for the treatment of melanoma in D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98e656d81cbb2a17d12a54e986954bd2
https://doi.org/10.4172/2471-8556.1000126
https://doi.org/10.4172/2471-8556.1000126